Chelation News/Articles

Here you find information relating to chelation therapy, its function, uses, application and all that is needed to know about this medical treatment.

It is our aim to provide reliable, scientifically-based information that aids doctors and patients alike.

Check for current updates.

MTM Research 2022

Alpha-Lipoic Acid, short ALA, can penetrate all areas of the nervous system. There is ample evidence that toxic metals such as mercury affect nerve function. Thus, a 'detoxification' of nerve cells should have a positive effect on their function. 

We just finished our study on comparing urine metal concentration before and after ALA treatment, and the results are promising. Results are in the publishing stage.

In the USA, a clinical study, now entering its second phase, is intended to show whether ALA treatment has a positive effect on the progression of Multiple Sclerosis. 

EDTA: Ethylene Diamine Tetra Acetic Acid - A Review by E. Blaurock-Busch, published in Occupational Medicine & Health Affairs 2016 4:4

Chelation therapists around the world incorporate EDTA treatments in their daily practice, often unaware of the chemical differences of the various chelating agents. Misunderstandings increase the risk of iatrogenic accidents. This information aims to prevent this.

Download article

Original Research Paper publ Jan 2014, British Journal of Medicine and Medical Research:

Comparison of Chelating Agents DMPS, DMSA and EDTA for the Diagnosis and Treatment of Chronic Metal Exposure

The chelating agents most commonly used to treat chronic metal overexposures are DMSA, DMPS and EDTA. We evaluated and compared the effectiveness of each of those chelating agents and statistically determined what metals are best bound. Based on the metal binding capacity and practicality of use, we determined that intravenously applied DMPS is best used as a provocation or mobilization test.

Read or download research paper

At present, it is assumed that the application of higher amounts of a chelating agent increases metal binding and thus the detoxification process. This does not seem to be the case. The manufacturer of DMPS (Dimaval), Heyl Berlin published data that indicate that for instance 2 or more ampules of DMPS intravenously applied do not result in double binding.

The same principle applies to other chelating agents. For example, when comparing 500mg to 1000mg DMSA applied orally, results do not increase as expected.

Study data and statistics are included.

Full article (in German only):
Download

Chelation therapy is used  for the treatment of chronic metal overexposures of varying degrees and appropriate diagnostics allow proper and safe treatment. The use of diagnostics aids the physician in setting therapy schedules, allows proper selection of the most useful chelating agent for the patient's condition, and monitors treatment success.

For detailed information, see our books.

The randomized, double-blind trial of NaMgEDTA Chelation provided surprising benefits for patients who had suffered at least one Myocardia Infarct (MI) and was particularly beneficial to increase circulation in diabetics, Dr. Gervasio Lamas of the Mount Sinai Medical Center, Miami Beach, Fl. stated.

Read more

Chelate substances or decorporation antidotes are used for metal detoxification or detoxification. They force the binding and excretion of the metal complexes produced. They are therefore complexing agents and are used to treat metal contamination used to treat metal pollution. So that the severity of a load can be assessed blood and urine tests are available. For the treatment of toxin contamination and the evaluation of the test results are subject to certain criteria apply.

If you want to find out more, read the following article (in German):

link